Microbiological Examinations - Lot 1 - Microbiological Examinations, Lot 2 - Drug Microbiology, Lot 3 - Microbiological And Chemical Studies In The Field Of Dialysis, Lot 4 - Microbiological Examinations Of Water
Microbiological Examinations - Lot 1 - Microbiological Examinations, Los 2 - Drug Microbiology, Lot 3 - Microbiological And Chemical Studies In The Field Of Dialysis, Lot 4 - Microbiological Examinations Of Water
Procurement of a PET-CT including maintenance for nuclear medicine
Framework Agreement For The Procurement Of Practical Needs For Bavarian Standby Practices
Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V To Pharmaceuticals With The Active Ingredient Budesonide (Except Inhalativa And At Least With An Approval For The Indication Of Chronic Inflammatory Bowel Disease) (Atc Code: A07Ea06).
Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V For Medicinal Products With The Active Ingredient Budesonide (Except Inhalativa And At Least With A Admission To The Indication Of Chronic Inflammatory Bowel Disease) (Atc Code: A07Ea .
Open Framework Agreement On Pharmaceutical Discounts In Accordance With Section 130A (8) Sgb V With Any Time, So-Called Registration Model 2025-09
Fraunhofer Community Exponate Medicine Of The Future 2026 Public Tender
Open Framework Agreement On Pharmaceutical Discounts In Accordance With Section 130A (8) Sgb V With Any Time, So-Called Registration Model 2025-09
Fraunhofer Community Exponate Medicine Of The Future 2026
Open House Biologika Discount Contracts 2025-26-Insulin Lispro (Atc: A10Ab04, Effectiveness: 100 U/Ml)
Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V On Pharmaceuticals With The Active Ingredient Tencilizumab (Atc Code: L04Ac07).
Delivery Of Edta Plasma
Test Pp 09.9.25
Electrical Installation Renovation, Expansion And Conversion Of The Former Pöllinger Building In A Citizens'/Medicine Center
Open House Original Discount Contracts 2025-26 - Ponesimod
Medicines And Medical Devices Subject To Pharmacy
Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V On Pharmaceuticals With The Active Ingredient Tencilizumab (Atc Code: L04Ac07).
Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So-Called Open House Process.
Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So-Called Open House Process.